We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed at $260.85 in the latest trading session, marking a -1.38% move from the prior day. This move lagged the S&P 500's daily loss of 0.45%. Meanwhile, the Dow experienced a drop of 0.63%, and the technology-dominated Nasdaq saw a decrease of 0.78%.
The stock of hospital operator has fallen by 0.02% in the past month, lagging the Medical sector's gain of 0.57% and overreaching the S&P 500's loss of 1.99%.
Market participants will be closely following the financial results of Tenet Healthcare in its upcoming release. The company is forecasted to report an EPS of $4.59, showcasing a 24.05% upward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $5.47 billion, reflecting a 3.4% rise from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $21.04 per share and a revenue of $22.2 billion, demonstrating changes of +25.39% and +4.18%, respectively, from the preceding year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.3% higher. Tenet Healthcare is currently sporting a Zacks Rank of #2 (Buy).
From a valuation perspective, Tenet Healthcare is currently exchanging hands at a Forward P/E ratio of 12.57. This expresses no noticeable deviation compared to the average Forward P/E of 12.57 of its industry.
We can also see that THC currently has a PEG ratio of 1.01. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. THC's industry had an average PEG ratio of 1.01 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 59, placing it within the top 24% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note
Tenet Healthcare (THC - Free Report) closed at $260.85 in the latest trading session, marking a -1.38% move from the prior day. This move lagged the S&P 500's daily loss of 0.45%. Meanwhile, the Dow experienced a drop of 0.63%, and the technology-dominated Nasdaq saw a decrease of 0.78%.
The stock of hospital operator has fallen by 0.02% in the past month, lagging the Medical sector's gain of 0.57% and overreaching the S&P 500's loss of 1.99%.
Market participants will be closely following the financial results of Tenet Healthcare in its upcoming release. The company is forecasted to report an EPS of $4.59, showcasing a 24.05% upward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $5.47 billion, reflecting a 3.4% rise from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $21.04 per share and a revenue of $22.2 billion, demonstrating changes of +25.39% and +4.18%, respectively, from the preceding year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.3% higher. Tenet Healthcare is currently sporting a Zacks Rank of #2 (Buy).
From a valuation perspective, Tenet Healthcare is currently exchanging hands at a Forward P/E ratio of 12.57. This expresses no noticeable deviation compared to the average Forward P/E of 12.57 of its industry.
We can also see that THC currently has a PEG ratio of 1.01. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. THC's industry had an average PEG ratio of 1.01 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 59, placing it within the top 24% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.